the economic and p ublic heal th v a l u e of self medic tion association eur opéenne des spécialités pharmaceutiques grand public european medication industr y opäischer fachverband der arzneimittel hersteller ue 7 avenue de t rvur en b 1040 brussels belgiumphone 32 2 735 51 30 fax 52 22 mail aesgp innet be executive summary 5 background part i analysis benefits based on an model 9 introduction 11 for europe wide 13 elements 14 type impact affected party 15 correlation between various savings 17 country analyses 19 austria france germany 25 italy 28 portugal 31 spain 34 united kingdom 37 projection in enlarged 40 42 ii rx to otc switching new indications health 45 47 case study vaginal mycosis 49 smoking cessation 54 iii heart disease prevention 62 66 policy recommendations 69 table
